Non-specific inhibition of prostaglandin (PG) synthesis reduces elevated pulmonary artery pressure (PAP) in animal models of newborn sepsis. We hypothesized that Tx was the PG which mediated the septic pulmonary hypertension, and investigated the effects of selective inhibition of Tx synthetase during Group B Streptococcal (GBS) sepsis in piglets.
4 piglets were anesthetized, intubated, ventilated and instrumented. Plasma Tx and prostacycl in (PC) metabol i tes were determined by RIA. Pulmonary hypertension was induced by continuous infusion of GBS. After induction of sepsis, PAP rose from 13+2 (SEM) to 4255 mmHg, and cardiac output (CO) dropped from 104F6 to 52+6. BP remained unchanged. Concurrently, TxB levels rose from 45ik264 to 3370t610 pg/ml (p<0.05) and 6 keto ~G F~~ levels rose from 323+55 to 13225569.
While GBS infusion continued, a thromboxane synthetase inhibitor, dazemgrel (Dz)(UK 38485) was then administered at 1 mg/kg. In response to treatment, PAP decreased rapidly to 16+1 mmHg, BP and CO remained stable. TxB2 levels dropped to 1960+3C0 and 6 keto PGF (a prostacycl in metabol i te) levels increased to 2090+363!~ . . . ~onclusions: I.GBS elevated PAP in piglets while raising both Tx8 and PC metabol ites. 2.Dz selectively reduced TxB and shunted 69 production towards PC. 3.Dz preferentially dimizished PAP during GBS sepsis. 4.Selective inh~bi tion of specific prostaglandins may benefit septic infants with elevated PAP. Ductal patency in the premature is associated with increased concentrations of dilator prostaglandins. lndomethacin is a general inhibitor of prostaglandin synthesis; therefore, it is more likely to be successful if levels of dilator prostaglandins are elevated than If not. Both 6 keto PGF , a stable metabolite of prostacyclin, and PGE have been demonlvrated to be increased in conjunction with pate$t ductus arteriosus. Plasma levels of these prostaglandins were measured by radioimmunoassay in ten prematures with PDA. Four of the ten infants studied had elevated 6 keto PGF levels (>500 pg/ml). All of these had a complete disappeara2e of their PDA murmur at 48 hours post therapy. Six infants had 6 keto PGF levels within normal limits. Of these, four had no response tbaindmethacin and were surgically ligated, and two had transient decreases in the intensity of their murmurs with subsequent recurrence i n general, varied z'keto PGF 40 hour response PGE2 la hesanedirectionas 153 None 52 did 6 keto PGF , how- Althouah intravenous veraoamil effectively terminates supraventricular tachycardia'(SVT) in children, its utility as a chronic oral antidysrhythmic drug has been disappointing. To assess whether drug kinetics contribute to this problem, we measured serum concentrations before and for 24 hours after a maintenance oral dose of verapamil (mean dose 1.36 mg/kg, range 0.4-2.9 mg/kg) in 7 children with a median age of 10.8 yrs (range 2.8-15.3 yrs). All had SVT controlled by chronic oral verapamil at mean serum peak and trough concentrations of 248+117 and 64238 ng/ml, respectively. We found several clearly age-dependent kinetic parameters: younger children demonstrated faster drug uptake "Tmax" (p <.005), lower relative bioavailability "F" (p < .01), smaller volume of distribution "Vd" (p <.005) and slower elimination half-life "t k 8 ' (p <.001).
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Younger children also exhibited a possible diurnal variation in drug kinetics. There was no siqnificant aqe-relationship in distribution half-life "tka "
or-drug clearance rate. Although these changes have opposing effects on serum concentrations, their net effect in young children is for a greater dosage requirement, and perhaps a shorter dosage interval, than are currently recommended.
* VIP relaxes cerebral vessels in vitro. Central nervous system (CNS) blood flow(BF) was measured (radioactive microspheres) in 6 -8 week piglets during vehicle infusion and at 10 min of VIP (lvg/kg/min, iv; plasma VIP of 9t2nglml). VIP increased heart rate (228t14 vs 13628 beatslmin, p<.001), reduced systemic pressure (64t5 vs 9223mmHg, p<.001), while CO was unchanged (276230 vs 261220ml/min/kg). Caudate nucleus, cerebral gray and white matter BF was reduced by 19 to 25% while regional resistance was unchanged. In contrast, resistance was reduced by 23-34% in the spinal cord, brain stem and cerebellum while BF was unchanged.
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Control VIP Control VIP ---- Netilmicin, an ethyl derivative of dehydrogenated gentamycin Cla, is the most recent addition to the aminoglycoside group of antimicrobial agents and is claimed to have less ototoxic and nephrotoxic potential than gentamycin. Twelve very immature preterm infants received therapy with ampicillin and netilmicin for suspected or proven sepsis. The median gestational age was 27 weeks (range 26-32 weeks), and the mean birth weight 1070 grams (range 760-1660 grams). They received 2.5 mg/kg 12 hourly by short intravenous infusion during the first week of life, and 2.5 mg/kg 8 hourly subsequently. Serum pharmacokinetics of netilmicin were determined after the initial dose of netilmicin. Serum trough levels were estimated 2-5 days after the commencement of therapy. The mean serum peak level 60 minutes after infusion was.5.9 mg/L, and the mean trough level was 1.8 mg1L. Elimination half lives correlated inversely with gestational and chronological age. In very immature preterm infants, the mean half lives were 8.4 hours in infants <7 days of age, and 3.6 hours in those age >7 days. The drug was well tolerated and no adverse effects were observed.
